Alteration of biophysical activity of pulmonary surfactant by aluminosilicate nanoparticles

Inhalation Toxicology

Volumn 25, Issue 2, 2013, Pages 77-83

  Kondej, Dorota ^a   Sosnowski, Tomasz R ^b  

^a CENTRAL INSTITUTE FOR LABOUR PROTECTION NATIONAL RESEARCH INSTITUTE   (Poland)

^b WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Adsorption; Clay NPs; Dynamic surface tension; Lung surfactant; Nanofillers

Indexed keywords

ALUMINOSILICATE CALCIUM; LUNG SURFACTANT;

AEROSOL; ARTICLE; BIOPHYSICS; HYSTERESIS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE TENSION;

ADSORPTION; ALUMINUM SILICATES; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; PULMONARY SURFACTANTS; SURFACE PROPERTIES;

EID: 84873285996     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2012.756087     Document Type: Article

References (36)

1. Bakand S, Hayes A, Dechsakulthorn F. (2012). Nanoparticles: a review of particle toxicology following inhalation exposure. Inhal Toxicol 24:125-35.
2. Bakshi MS, Zhao L, Smith R, et al. (2008). Metal nanoparticle pollutants interfere with pulmonary surfactant function in vitro. Biophys J 94: 855-68. (Pubitemid 351162452)
3. Clements JA, Hustead RF, Johnson RP. (1961). Pulmonary surface tension and alveolar stability. J Appl Physiol 16:444-50.
4. Card JW, Zeldin DC, Bonner JC, Nestmann ER. (2008). Pulmonary applications and toxicity of engineered nanoparticles. Am J Physiol Lung Cell Mol Physiol 295:L400-11.
5. Engle WA, the Committee on Fetus and Newborn. (2008). Surfactantreplacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 121:419-32.
6. Fan Q, Wang YE, Zhao X, et al. (2011). Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant. ACS Nano 5:6410-16.
7. Geiser M, Kreyling WG. (2010). Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol 7:2. Available from: http:// www.particleandfibretoxicology.com/content/7/1/2
8. Gradoń L, Podgorski A. (1989). Hydrodynamical model of pulmonary clearance. Chem Eng Sci 44:741-9.
9. Grim RE. (1968). Clay mineralogy. New York: McGraw-Hill.
10. Guzman E, Liggieri L, Santini E, et al. (2011). Effect of hydrophilic and hydrophobic nanoparticles on the surface pressure response of DPPC monolayers. J Phys Chem C 115:21715-22.
11. Hall SB, Lu RZ, Venkitaraman AR, et al. (1992). Inhibition of pulmonary surfactant by oleic acid: mechanisms and characteristics. J Appl Physiol 72:1708-16.
12. Harishchandra RK, Saleem M, Galla H-J. (2010). Nanoparticle interaction with model lung surfactant monolayers. J R Soc Interface 7:S15-26.
13. Kondej D, Sosnowski TR. (2010). The influence of metal-containing occupational dust on pulmonary surfactant activity. Chem Eng Trans 19:315-20.
14. Kondej D, Sosnowski TR. (2013). Surface properties of the lung surfactant monolayer as an indicator of the influence of inhaled mineral nanoparticles on respiratory functions. Submitted to 9th European Conference of Chemical Engineering; 2013 Apr 21- 24; The Hague, The Netherlands.
15. Lam BC, Ng YK, Wong KY. (2005). Randomized trial comparing two natural surfactants (Survanta vs. bLES) for treatment of neonatal respiratory distress syndrome. Pediatr Pulmonol 39:64-9. (Pubitemid 39628606)
16. Luther W, ed. (2004). Industrial application of nanomaterials - chances and risks. Technology analysis. Dusseldorf, Germany: Future Technologies Division of VDI Technologiezentrum GmbH.
17. Lvov YM, Shchukin DG, Mohwald H, Price RR. (2008). Halloysite clay nanotubes for controlled release of protective agents. ACS Nano 2:814-20.
18. Lyyranen J, Hokkinen J, Backman U, et al. (2012). Particle characterisation during melting of nanoparticle containing coated and uncoated window glass. In: European Aerosol Conference 2012 Book. Granada, Spain: University of Granada, B-WG07S1P42.
19. Marijnissen J, Gradoń L, eds. (2010). Nanoparticles in medicine and environment. Inhalation and health effects. Dordrecht, the Netherlands: Springer.
20. Mills NL, Amin N, Robinson SD, et al. (2006). Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med 173:426-31. (Pubitemid 43228331)
21. Moller W, Felten K, Sommerer K, et al. (2008). Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med 177:426-32. (Pubitemid 351317586)
22. Nieman GF, Bredenberg CE. (1985). High surface tension pulmonary edema induced by detergent aerosol. J Appl Physiol 58:129-36. (Pubitemid 15054388)
23. Notter RH, Taubold R, Mavis RD. (1982). Hysteresis in saturated phospholipid and its potential relevance in vivo. Exp Lung Res 3:109-27.
24. Oberdorster G, Sharp Z, Atudorei V, et al. (2004). Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437-45. (Pubitemid 38685135)
25. Podgorski A, Gradoń L. (1993). An improved mathematical model of hydrodynamical self-cleansing of pulmonary alveoli. Ann Occup Hyg 37:347-65. (Pubitemid 23262055)
26. Schleh C, Muhlfeld C, Pulskamp K, et al. (2009). The effect of titanium dioxide nanoparticles on pulmonary surfactant function and ultrastructure. Respir Res 10:90. Available from: http://respiratoryresearch. com/content/10/1/90
27. Schurch S, Gehr P, Im Hof V, et al. (1990). Surfactant displaces particles toward the epithelium in airways and alveoli. Respir Physiol 80:17-32. (Pubitemid 20160258)
28. Sosnowski TR, Gradoń L. (2010). Modification of inhalable powders by pulmonary surfactant components adsorbed on droplets during spray-drying process. Colloids Surf A 365:56-61.
29. Sosnowski TR, Gradoń L, Iskandar F, Okuyama K. (2003). Interaction of deposited aerosol particles with the alveolar liquid layer. In: Gradoń L, Marijnissen J, eds. Optimization of aerosol drug delivery. Dordrecht, the Netherlands: Kluwer, 205-16.
30. Sosnowski TR, Gradoń L, Podgorski A. (2000). Influence of insoluble aerosol deposits on the surface activity of the pulmonary surfactant: A possible mechanism of alveolar clearance retardation? Aerosol Sci Technol 32:52-60. (Pubitemid 32006415)
31. Sosnowski TR, Kolin'ski M, Gradoń L. (2011). Interactions of benzo[a]pyrene and diesel exhaust particulate matter with the lung surfactant system. Ann Occup Hyg 55:329-38.
32. Sosnowski TR, Podgorski A. (1999). Assessment of the pulmonary toxicity of inhaled gases and particles with physicochemical methods. Int J Occup Safety Ergon 5:433-49.
33. Wallace WE, Keane MJ, Murray DK, et al. (2006). Phospholipid lung surfactant and nanoparticle surface toxicity: lessons from diesel soots and silicate dusts. J Nanopart Res 9:23-38. (Pubitemid 46036108)
34. Yang W, Peters JI, Williams III RO. (2008). Inhaled nanoparticles - a current review. Int J Pharm 356:239-47.
35. Zasadzinski JA, Stenger PC, Shieh I, Dhar P. (2010). Overcoming rapid inactivation of lung surfactant: analogies between competitive adsorption and colloid stability. Biochim Biophys Acta 1798: 801-28.
36. Zuo YY, Veldhuizen RAW, Neumann AW, et al. (2008). Current perspectives in pulmonary surfactant-inhibition, enhancement and evaluation. Biochim Biophys Acta 1778:1947-77.